This #InternationalPodcastDay, we are showcasing some of the conversations that help fuel progress! 🎙️ 🔬 Earlier this year, Charlotte Barker spoke with Giorgio Zenere, PhD, MBA (Kite Pharma) and Dirk Windgassen (Miltenyi Biotec) to discuss the important role robust potency assays play in transforming the therapeutic promise of cell and gene therapies into clinical reality. You can have a listen to the discussion at the link below: https://buff.ly/450EgKD Want to stay up to date with all the latest from the BioInsights Podcast? Follow us at the link below or on Spotify, Apple Podcasts, or wherever you stream, to stay up to date with the latest from BioInsights https://buff.ly/4eMYtr3 #InternationalPodcastDay #CellAndGeneTherapy #PotencyAssays #genetherapy #celltherapy
About us
BioInsights was founded with the vision of publishing high-quality research and commentary in areas of bioscience that offer true potential to revolutionize modern healthcare. Our peer-reviewed, open access publications include Cell and Gene Therapy Insights, Immuno-Oncology Insights, Vaccine Insights and - our newest journal - Nucleic Acid Insights. Our publications provide rapid analysis of cutting-edge technological advances and facilitate debate and discussion by all stakeholders committed to progressing clinical translation and commercialization in these exciting fields. Register at www.insights.bio for free access to original research, review, commentary, and interview articles, as well as webinars and video roundtables.
- Website
-
http://www.insights.bio
External link for BioInsights
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Publishing, Bioscience, Cell therapy, Gene therapy, Vaccines, and Immuno-Oncology
Locations
-
Primary
London, GB
Employees at BioInsights
Updates
-
How can you overcome the complexities of AAV purification to ensure both high purity and yield, while scaling up for large-scale manufacturing? Our founder, Elisa Manzotti, recently had the privilege of moderating an expert panel discussion alongside William Kish (Taysha Gene Therapies), Matthew Roach (BridgeBio) Nathalie Clement (Siren Biotechnology), and Nicolas Laroudie (Thermo Fisher Scientific), as they shared their experiences and expert insights into addressing the toughest hurdles in AAV downstream processing. Key points in their discussion included: • Navigating purification complexities to maximize yield and purity • Optimizing upstream processes with downstream needs in mind • Ensuring scalability and reproducibility for large-scale manufacturing • Meeting critical regulatory guidelines Did you miss this live discussion? You can view the webinar at your convenience below: https://lnkd.in/e7c-xfmE #AAV #GeneTherapy #Biotech #DownstreamProcessing #Scalability #Webinar
-
Don't miss out on the July Nucleic Acid Insights issue! In this month's edition, we explore nonclinical tools and technologies being employed in the clinical translation of #mRNAtherapeutics, and investigate the key challenge of enhancing the stability of #nucleicaciddrugs in vivo. View below:
Vol 1 Issue 6
insights.bio
-
Don't miss out on the June Cell and Gene Therapy Insights issue! Featuring this month's spotlight content: Viral and non-viral vector platform evolution View below:
Vol 10 Issue 5
insights.bio
-
Don't miss out on the May Vaccine Insights issue! Featuring this month's spotlight content: RNA vaccines: research directions View below:
Vol 3 Issue 3
insights.bio
-
Don't miss out on the May Nucleic Acid Insights issue! Featuring this month's spotlight content: mRNA processing and analysis View below:
Vol 1 Issue 4
-
Don't miss out on the April Cell & Gene Therapy Insights issue! Featuring this month's spotlight content: Vector processing and materials View below:
Vol 10 Issue 3
-
Don't miss out on the March Immuno-oncology Insights issue! Featuring this month's spotlight content: Combination therapy development View below:
Vol 5 Issue 2
insights.bio
-
Don't miss out on the March Cell & Gene Therapy Insights issue! Featuring this month's spotlight content: Non-clinical/translational tools & technologies View below:
Vol 10 Issue 2
insights.bio